Test

Phillip J. Koo, MD, gives a high-level overview of the current state of molecular targeted imaging in identifying prostate cancer.

Alejandro R. Rodriguez, MD, discusses the management of metabolic, cardiovascular, and other side-effects of androgen deprivation therapy.

Neil H. Baum, MD, interviews Alan Wein, MD, PhD, FACS, on the past, present, and future of overactive bladder treatment in Urology.

R. Caleb Kovell, MD, discusses management strategies for acute refractory ischemic priapism, including shunting, tunneling, and prosthesis.

Scott B. Sellinger, MD, FACS, addresses ADT's impact on bone health and other non-cardiovascular side effects of the therapy.

Mohit Khera, MD, MBA, MPH, presents the latest updates from the TRAVERSE Trial, examining the cardiovascular effects of testosterone therapy.